Mdig gene and histone demethylation in lung cancer
Mdig gene and histone demethylation in lung cancer
批准号:
8236086
负责人:
Fei Chen
金额:
$16.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2014-02-28
中文摘要
描述(由申请人提供):肺癌是全球最常见的癌症,每年有130万人死于癌症。尽管人们做出了广泛的努力来阐明机制并开发新的治疗方案,但全球肺癌的死亡率仍然很高。我们的长期目标是了解mdig基因在人类肺癌发生发展中的作用,以及mdig基因是否可以作为环境或职业危害所致肺癌的生物标志物和治疗靶点。本申请的目的是研究Mdig蛋白在环境和职业危害/致癌物诱导的肺细胞增殖和致癌转化中的作用。中心假设是Mdig通过作为组蛋白脱甲基酶拮抗组蛋白H3上的三甲基赖氨酸9来促进细胞生长和转化。下调组蛋白H3的三甲基赖氨酸9的表达,将增强与细胞周期调控和肺上皮细胞恶性转化相关基因的表达。这一建议背后的基本原理是mdig基因的表达可能是肺细胞增殖和致癌转化的关键,以应对环境致癌物。为了实现本申请的目的,我们将通过使用细胞系和裸鼠作为实验模型来追求三个具体目标:(1)测试mdig蛋白对组蛋白H3上的三甲基化赖氨酸9的潜在脱甲基酶活性;(2)确定细胞周期调节基因(例如细胞周期蛋白、Cdc 25和检查点蛋白)的表达是否受mdig的甲基化调节的调节;(3)通过细胞培养和裸鼠体内接种两种方法,研究mdig在BEAS-2B细胞和A549细胞中过表达和下调mdig的致瘤作用。在完成这些特定目标后,我们期望能够确定mdig如何促进肺细胞生长调节和致癌转化,以应对导致肺癌的因素。基于初步研究,我们还期望mdig的组成型表达将损害组蛋白H3上赖氨酸9的三甲基化,导致异染色质的减弱或其他抑制性表观遗传标记的形成。因此,与细胞周期转换和细胞增殖相关的基因的表达将增强。最后,除了揭示一个以前未知的人肺癌的新机制外,预期mdig的表达可潜在地作为人肺癌的新生物标志物和治疗靶点。公共卫生相关性:肺癌是美国(US)恶性肿瘤相关死亡的主要原因。它比任何其他类型的恶性肿瘤杀死更多的美国人。肺癌的主要原因是环境和职业暴露于致癌物,包括吸烟和职业粉尘。本项目将通过验证mdig基因通过下调组蛋白H3上赖氨酸9的三甲基化和异染色质的形成来诱导细胞生长和转化的假说,探讨mdig基因这一新发现的肺癌相关基因介导致癌物诱导肺癌的机制。本研究的长期目标是了解mdig基因在环境和职业危害诱发的肺癌发生和发展中的作用,寻找早期发现肺癌的生物标志物,并制定干预和预防策略。
英文摘要
DESCRIPTION (provided by applicant): Lung cancer is the most common cancer worldwide, accounting for 1.3 million cancer deaths annually. Despite extensive efforts to elucidate mechanisms and develop new therapeutic regimens, the worldwide mortality rate of lung cancer remains high. Our long- term goal is to understand how mdig gene contributes to the initiation and progression of the human lung cancer and whether mdig can be served as a biomarker and a therapeutic target for lung cancer resulted from exposure to environmental or occupational hazards. The objective of this application is to investigate the role of Mdig protein played on the lung cell proliferation and carcinogenic transformation induced by environmental and occupational hazards/carcinogens. The central hypothesis is that Mdig promotes cell growth and transformation by functioning as a histone demethylase that antagonizes tri-methyl lysine 9 on histone H3. Down-regulation of tri-methyl lysine 9 of histone H3 will enhance the expression of genes associated with the cell cycle regulation and malignant transformation in lung epithelial cells. The rationale behind this proposal is that expression of mdig gene may be critical for lung cell proliferation and carcinogenic transformation in response to environmental carcinogens. To accomplish the objectives of this application, we will pursue three specific aims by using cell lines and nude mice as experimental models: (1) test the potential demethylase activity of mdig protein toward tri-methylated lysine 9 on histone H3; (2) determine whether the expression of the cell cycle-regulated genes, such as cyclins, Cdc25s and checkpoint proteins, is regulated by the methylation regulation of mdig; and (3) study the tumorigenic effect of mdig by both over- expression and down-regulation of mdig in BEAS-2B cells and A549 cells, respectively, in both cell culture and inoculation of the cells in nude mice. At the completion of these specific aims, we expect to have determined how mdig contributes to lung cell growth regulation and carcinogenic transformation in response to factors that cause lung cancer. We additionally expect, based on preliminary studies, that constitutive expression of mdig will compromise the tri-methylation of lysine 9 on histone H3, leading to attenuation of heterochromatin or the formation of other inhibitory epigenetic markers. As a result, the expression of genes associated with the cell cycle transition and cell proliferation will be enhanced. Finally, in addition to reveal a previously unknown new mechanism of the human lung cancer, it is anticipated that expression of mdig can be potentially served as a new biomarker and therapeutic target of the human lung cancer. PUBLIC HEALTH RELEVANCE: Lung cancer is the leading cause of malignant-related deaths in the United States (US). It kills more Americans than any other type of malignancy. The main cause of lung cancer is the environmental and occupational exposure to carcinogens, including tobacco smoking and occupational dust. This project will investigate the mechanism of mdig gene, a newly identified lung cancer associated gene, in mediating carcinogen-induced lung cancer by testing the hypothesis that mdig inducing cell growth and transformation through down regulation of the tri-methylation of lysine 9 on histone H3 and the heterochromatin formation. The long-term goals are to understand how mdig gene contributes to the initiation and progression of the human lung cancer induced by environmental and occupational hazards, to identify biomarkers for early detection of the lung cancer and to develop intervention and prevention strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Spatial genomic tools to interrogate T cell clonotypes, tumor clones and the microenvironment
-
批准号:10565141
-
项目类别:
-
资助金额:$69.13万
-
财政年份:2023
-
负责人:Fei Chen
-
依托单位:
Dissecting Nrf2-dependent HIF1a activation mechanism in arsenic-induced cancer stem-like cells
-
批准号:10435281
-
项目类别:
-
资助金额:$29.41万
-
财政年份:2021
-
负责人:Fei Chen
-
依托单位:
Arsenic-Induced miRNA-199 and mriRNA-214 Deplete Mitochondrial DNA for the Generation of Cancer Stem-Like Cells
-
批准号:10489836
-
项目类别:
-
资助金额:$27.15万
-
财政年份:2021
-
负责人:Fei Chen
-
依托单位:
Dissecting Nrf2-dependent HIF1a activation mechanism in arsenic-induced cancer stem-like cells
-
批准号:10316248
-
项目类别:
-
资助金额:$35.55万
-
财政年份:2021
-
负责人:Fei Chen
-
依托单位:
Arsenic-Induced miRNA-199 and mriRNA-214 Deplete Mitochondrial DNA for the Generation of Cancer Stem-Like Cells
-
批准号:10463263
-
项目类别:
-
资助金额:$27.15万
-
财政年份:2021
-
负责人:Fei Chen
-
依托单位:
Reduced Reactive Oxygen Species and Oxidative Phosphorylation in Arsenic-Induced Cancer Stem Cells
-
批准号:10441939
-
项目类别:
-
资助金额:$35.55万
-
财政年份:2021
-
负责人:Fei Chen
-
依托单位:
Dissecting Nrf2-dependent HIF1a activation mechanism in arsenic-induced cancer stem-like cells
-
批准号:10515655
-
项目类别:
-
资助金额:$35.55万
-
财政年份:2021
-
负责人:Fei Chen
-
依托单位:
A high-resolution molecular and lineage atlas of the mouse brain using Slide-seq
-
批准号:10088261
-
项目类别:
-
资助金额:$190.31万
-
财政年份:2020
-
负责人:Fei Chen
-
依托单位:
A cellular atlas of the primate and human basal ganglia
-
批准号:10527335
-
项目类别:
-
资助金额:$170.66万
-
财政年份:2020
-
负责人:Fei Chen
-
依托单位:
COVID19 Slide-seq
-
批准号:10173485
-
项目类别:
-
资助金额:$17.37万
-
财政年份:2019
-
负责人:Fei Chen
-
依托单位:
A single cell spatial genomics platform for multi-modal characterization of tissue organization
-
批准号:10408000
-
项目类别:
-
资助金额:$94.64万
-
财政年份:2019
-
负责人:Fei Chen
-
依托单位:
A single cell spatial genomics platform for multi-modal characterization of tissue organization
-
批准号:9797023
-
项目类别:
-
资助金额:$94.64万
-
财政年份:2019
-
负责人:Fei Chen
-
依托单位:
Arsenic-induced miRNA-199 and miRNA-214 deplete mitochondrial DNA for the generation of cancer stem-like cells
-
批准号:9521211
-
项目类别:
-
资助金额:$26.36万
-
财政年份:2018
-
负责人:Fei Chen
-
依托单位:
Arsenic-induced miRNA-199 and miRNA-214 deplete mitochondrial DNA for the generation of cancer stem-like cells
-
批准号:9926262
-
项目类别:
-
资助金额:$26.36万
-
财政年份:2018
-
负责人:Fei Chen
-
依托单位:
Reduced reactive oxygen species and oxidative phosphorylation in arsenic-induced cancer stem cells
-
批准号:9366680
-
项目类别:
-
资助金额:$33.73万
-
财政年份:2017
-
负责人:Fei Chen
-
依托单位:
Characterizing glioma heterogeneity with novel multiplexed nanoscale imaging technologies
-
批准号:10247568
-
项目类别:
-
资助金额:$44.5万
-
财政年份:2017
-
负责人:Fei Chen
-
依托单位:
MicroRNA-190 and Oxidative Stress in Arsenic carcinogenesis
-
批准号:8370816
-
项目类别:
-
资助金额:$35.04万
-
财政年份:2012
-
负责人:Fei Chen
-
依托单位:
MicroRNA-190 and Oxidative Stress in Arsenic carcinogenesis
-
批准号:8689015
-
项目类别:
-
资助金额:$33.62万
-
财政年份:2012
-
负责人:Fei Chen
-
依托单位:
MicroRNA-190 and Oxidative Stress in Arsenic carcinogenesis
-
批准号:9065549
-
项目类别:
-
资助金额:$33.96万
-
财政年份:2012
-
负责人:Fei Chen
-
依托单位:
MicroRNA-190 and Oxidative Stress in Arsenic carcinogenesis
-
批准号:8538383
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2012
-
负责人:Fei Chen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
热激蛋白HSP101新等位变异基因NTRF1(neo-tetraploid rice fertile gene 1)调控新型四倍体水稻高育性的分子机理
-
批准号:32572292
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2025
-
负责人:刘向东
-
依托单位:
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
-
批准号:82371801
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:周海波
-
依托单位:
Pik3r2基因突变在家族内侧颞叶癫痫中的作用及发病机制研究
-
批准号:82371454
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:郝勇
-
依托单位:
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
-
批准号:82370906
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:代杰文
-
依托单位:
发展基因编码的荧光探针揭示趋化因子CXCL10的时空动态及其调控机制
-
批准号:32371150
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:井淼
-
依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
-
批准号:82371141
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈颖
-
依托单位:
RET基因634位点不同氨基酸改变对甲状腺C细胞的影响与机制研究
-
批准号:82370790
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶蕾
-
依托单位:
lncGEI诱导湖羊卵巢颗粒细胞E2合成的分子机制
-
批准号:32372856
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李隐侠
-
依托单位:
KMT2A基因突变通过DNMT3靶向调控GBP2导致神经发育障碍的机制研究
-
批准号:82371867
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王剑
-
依托单位:
综合医疗机构引入Gene-Xpert MTB/RIF技术早期发现传染性肺结核和耐药肺结核的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:
-
依托单位: